New approaches in the treatment of type 2 diabetes
- 25 July 2000
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 4 (4) , 461-467
- https://doi.org/10.1016/s1367-5931(00)00103-4
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A Ureido-Thioisobutyric Acid (GW9578) Is a Subtype-Selective PPARα Agonist with Potent Lipid-Lowering ActivityJournal of Medicinal Chemistry, 1999
- Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in MiceScience, 1999
- Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein Tyrosine Phosphatase-1B GeneScience, 1999
- Discovery and Structure−Activity Relationship of the First Non-Peptide Competitive Human Glucagon Receptor AntagonistsJournal of Medicinal Chemistry, 1998
- Glucagon-like peptidesDiabetes, 1998
- Pure Glucagon Antagonists: Biological Activities and cAMP Accumulation Using Phosphodiesterase InhibitorsPeptides, 1997
- The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.Journal of Clinical Investigation, 1996
- In vivo andin vitro studies of vanadate in human and rodent diabetes mellitusMolecular and Cellular Biochemistry, 1995
- CP-99,711: a non-peptide glucagon receptor antagonistBioorganic & Medicinal Chemistry Letters, 1992
- Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabeticsDiabetes, 1987